Medical Journal of Australia Journal

Overview
Identity
View All

publication venue for

Pulmonary embolism: update on diagnosis and management. 211:82-87. 2019
Deep vein thrombosis: update on diagnosis and management. 210:516-524. 2019
An overview of the GRADE approach and a peek at the future. 209:291-292. 2018
Network meta‐analysis in health care decision making. 209:151-154. 2018
The value of novel oral anticoagulants in rural Australia. 208:15-16. 2018
Faecal microbiota transplantation for Clostridium difficile-associated diarrhoea: a systematic review of randomised controlled trials.. 207:166-172. 2017
Faecal microbiota transplantation for Clostridium difficile ‐associated diarrhoea: a systematic review of randomised controlled trials. 207:166-172. 2017
Is there really misuse and abuse of dabigatran?. 198:358-359. 2013
A meta‐analysis of “hospital in the home”. 197:512-519. 2012
Should adult patients be routinely tested for heritable thrombophilia after an episode of venous thromboembolism?. 195:139-142. 2011
Clinical practice guidelines: the need for greater transparency in formulating recommendations. 195:29-33. 2011
Accidental ingestion of plastic from takeaway containers — food for thought. 194:245-246. 2011
From neuroprogression to neuroprotection: implications for clinical care. 193:S36-S40. 2010
From neuroprogression to neuroprotection: implications for clinical care.. 193:S36-S40. 2010
Role of triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents. 192:487-488. 2010
Duration of anticoagulant therapy for venous thromboembolism. 190:659-660. 2009
The incidence of venous thromboembolism: a prospective, community‐based study in Perth, Western Australia. 189:144-147. 2008
Measuring patient‐reported outcomes: moving from clinical trials into clinical practice. 189:93-94. 2008
Will prasugrel supersede clopidogrel for acute coronary syndromes?. 188:381-382. 2008
Simplifying the diagnosis of pulmonary embolism. 187:325-326. 2007
The relationship between compensable status and long‐term patient outcomes following orthopaedic trauma. 187:14-17. 2007
Guidelines for the management of acute coronary syndromes 2006. 186:101-102. 2007
General practitionersˈ experiences of managing patients with chronic leg ulceration. 185:78-81. 2006
In reply [7]. 184:143. 2006
Safety of hospital in the home. 184:143-143. 2006
Predicting commercial success for Australian medical inventions patented in the United States: a cross sectional survey of Australian inventors. 184:33-38. 2006
Home management of mild to moderately severe community‐acquired pneumonia: a randomised controlled trial. 183:235-238. 2005
Resolving conflict in end‐of‐life care. 183:230-231. 2005
Venous thromboembolism: diagnosis and management of pulmonary embolism - Reply. 183:221-221. 2005
Venous thromboembolism: diagnosis and management of pulmonary embolism.. 183:220-221. 2005
Venous thromboembolism: diagnosis and management of pulmonary embolism. 183:220-221. 2005
Venous thromboembolism: diagnosis and management of pulmonary embolism. 182:569-574. 2005
Venous thromboembolism: diagnosis and management of deep venous thrombosis. 182:476-481. 2005
Cardiovascular safety of rofecoxib (Vioxx): lessons learned and unanswered questions. 182:199-199. 2005
Cardiovascular safety of rofecoxib (Vioxx): lessons learned and unanswered questions. 181:524-525. 2004
Clinical usefulness of plasma homocysteine in vascular disease. 181:314-318. 2004
Medical registry governance and patient privacy. 181:125-126. 2004
Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications. 181:150-154. 2004
The beginning of the end of warfarin?. 180:549-551. 2004
Preventing pressure ulcers. 180:316-316. 2004
Complementary medicine: is it more acceptable in palliative care practice?. 179:S46-S48. 2003
Long‐term management of venous thromboembolism: is there a role for low‐intensity warfarin therapy?. 179:68-69. 2003
Antiplatelet drugs. 178:568-574. 2003
In reply: How long should drug treatment of depression last?. 178:526-527. 2003
Determining the sample size in a clinical trial. 178:358-358. 2003
In reply: Low‐molecular‐weight heparins and heparinoids. 178:414-415. 2003
Low‐molecular‐weight heparins and heparinoids. 178:413-414. 2003
Aspirin for the primary prevention of cardiovascular events. 177:343-344. 2002
Low molecular weight heparins and heparinoids. 177:379-383. 2002
Grief and loss: past, present and future. 177:176-177. 2002
Is aggressive lipid‐lowering therapy preferable to angioplasty in stable coronary artery disease?. 175:492-493. 2001
The changing face of dying in Australia. 175:508-510. 2001
Australian medical patents granted in the United States in 1984‐1999. 174:83-87. 2001
General practitioners' attitudes to randomised clinical trials for women with breast cancer. 171:303-305. 1999
Measuring the success of joint replacement surgery. 171:229-230. 1999
Venous thrombosis and hyperhomocysteinaemia. 169:313-315. 1998
Treatment decision‐making at the end of life: a survey of Australian doctors' attitudes towards patients' wishes and euthanasia. 165:540-544. 1996
Accidental infant death and stroller‐prams. 165:140-141. 1996
Malignancy in chronic leg ulcers. 164:718-720. 1996
Diagnosis of deep vein thrombosis. 163:509-510. 1995
Helicobacter pyloriand gastric neoplasia: evolving concepts. 163:253-255. 1995
The acquired immunodeficiency syndrome in Australia: incidence 1982–1991. 158:10-17. 1993
General practitioners' attitudes to computer‐generated surgical discharge letters. 157:380-382. 1992
A survey of current prescribing practices of anti‐inflammatory and urate‐lowering drugs in gouty arthritis in New South Wales and Queensland. 151:531-537. 1989
Cot deaths in Australia. 145:359-360. 1986
Beta‐adrenergic blockade and peripheral vascular disease. 1:509-511. 1982
The Australian general practice morbidity and prescribing survey, 1969 to 1974. 6. Prescribing: oral contraceptives.. 2:23-27. 1976
SUDDEN INFANT DEATH SYNDROME IN SOUTH AUSTRALIA. MEASUREMENT OF SERUM IgE ANTIBODIES TO THREE COMMON ALLERGENS. 2:855-859. 1975
VON WILLEBRAND'S DISEASE. 2:565-565. 1973
A MULTI–ACCESS INTERFACE FOR THE DISABLED (MAID). 1:300-302. 1973
INDEPENDENT LOGIC DURATOR. 1:130-131. 1973
ANTICOAGULANTS AFTER OPEN‐HEART SURGERY. 2:5-6. 1970
EVALUATION OF SUBCUTANEOUS CALCIUM HEPARIN THERAPY IN THE TREATMENT OF THROMBO‐EMBOLIC DISEASE. 1:15-17. 1970
ARTERIAL THROMBOSIS IN A PATIENT WITH CHRONIC THROMBOCYTOPENIA SUCCESSFUL TREATMENT WITH INTRAARTERIAL INFUSION OF STREPTOKINASE. 2:1304-1306. 1969
HEPARIN IN THE TREATMENT OF VENOUS THROMBOEMBOLIC DISEASE: ADMINISTRATION, CONTROL AND RESULTS. 2:153-159. 1968
THE TREATMENT OF HAEMOPHILIA A WITH ANTI‐HAEMOPHILIC FACTOR. 1:445-446. 1966
THE HUMAN PLATELET; A CRITICAL REVIEW. 1:197-201. 1966
ON THE BLEEDER: A CASE OF VON WILLEBRAND'S DISEASE AND ITS TREATMENT WITH HUMAN ANTI-HAEMOPHILIC FACTOR.. 15:453-455. 1963
ON THE BLEEDER: A CASE OF VON WILLEBRAND'S DISEASE AND ITS TREATMENT WITH HUMAN ANTI‐HÆMOPHILIC FACTOR. 2:453-455. 1963

has subject area

11 Medical and Health Sciences (FoR)
17 Psychology and Cognitive Sciences (FoR)
General & Internal Medicine (Science Metrix)